BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6345422)

  • 21. Radioimmunoassay for vasoactive intestinal polypeptide (VIP) in plasma before and during endoscopic examinations.
    Hossdorf T; Burger M; Burger M; Karoff C; van Husen N; Wagner H
    Hepatogastroenterology; 1982 Aug; 29(4):146-50. PubMed ID: 7129338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of duodenal infusion of graded doses of HCL on plasma secretin and vasoactive intestinal polypeptide (VIP), and on duodenal bicarbonate secretion in man.
    Lygren I; Burhol PG; Waldum HL; Jorde R
    Mater Med Pol; 1980; 12(4):223-8. PubMed ID: 7266047
    [No Abstract]   [Full Text] [Related]  

  • 23. Gemfibrozil: effect on serum lipids, lipoproteins, postheparin plasma lipase activities and glucose tolerance in primary hypertriglyceridaemia.
    Nikkilä EA; Ylikahri R; Huttunen JK
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):58-63. PubMed ID: 190608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating gastrointestinal hormone changes in marathon running.
    O'Connor AM; Johnston CF; Buchanan KD; Boreham C; Trinick TR; Riddoch CJ
    Int J Sports Med; 1995 Jul; 16(5):283-7. PubMed ID: 7558523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Gastrointestinal hormones: present status].
    Klapdor R
    Med Lab (Stuttg); 1979 Apr; 32(4):71-88. PubMed ID: 220513
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of metformin treatment on gastric acid secretion and gastrointestinal hormone levels in normal subjects.
    Molloy AM; Ardill J; Tomkin GH
    Diabetologia; 1980 Aug; 19(2):93-6. PubMed ID: 7418969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Basal hyperchlorhydria and its relation to the plasma concentrations of secretin, vasoactive intestinal polypeptide (VIP) and gastrin during prolonged strain.
    Oektedalen O; Opstad PK; Schaffalitzky de Muckadell OB; Fausa O; Flaten O
    Regul Pept; 1983 Feb; 5(3):235-44. PubMed ID: 6844664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of glucagon, secretin, and vasoactive intestinal polypeptide on gastric somatostatin and gastrin release from isolated perfused rat stomach.
    Chiba T; Taminato T; Kadowaki S; Abe H; Chihara K; Seino Y; Matsukura S; Fujita T
    Gastroenterology; 1980 Jul; 79(1):67-71. PubMed ID: 6103859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of starvation on the gastro-entero-pancreatic hormonal and metabolic responses to exercise. (GEP hormones in starvation and exercise).
    Bell PM; Henry RW; Buchanan KD; Alberti KG
    Diabete Metab; 1984 Sep; 10(3):194-8. PubMed ID: 6386559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hormonal changes after Roux-en Y gastric bypass for morbid obesity and the control of type-II diabetes mellitus.
    Clements RH; Gonzalez QH; Long CI; Wittert G; Laws HL
    Am Surg; 2004 Jan; 70(1):1-4; discussion 4-5. PubMed ID: 14964537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fat-induced jejunal inhibition of gastric acid secretion and release of pancreatic glucagon, enteroglucagon, gastric inhibitory polypeptide, and vasoactive intestinal polypeptide in man.
    Christiansen J; Bech A; Fahrenkrug J; Holst JJ; Lauritsen K; Moody AJ; Schaffalitzky de Muckadell O
    Scand J Gastroenterol; 1979; 14(2):161-6. PubMed ID: 107575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma vasoactive intestinal polypeptide and other regulatory peptides in children with neurogenic tumours.
    Tiedemann K; Long RG; Pritchard J; Bloom SR
    Eur J Pediatr; 1981 Oct; 137(2):147-50. PubMed ID: 7308225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Responses of vasoactive intestinal polypeptide, secretin, and human pancreatic polypeptide to glucose during fasting.
    Oktedalen O; Opstad PK; Jorde R; Schaffalitzky de Muckadell OB
    Scand J Gastroenterol; 1984 Jan; 19(1):59-64. PubMed ID: 6710078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of caloric intake on gastric inhibitory polypeptide, VIP and gastrin release in man.
    Beck B; Villaume C; Chayvialle JA; Gariot P; Ulmer M; Desalme A; Debry G
    Peptides; 1984; 5(2):403-6. PubMed ID: 6473163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The gastroenteroinsular response to glucose ingestion during postexercise recovery.
    O'Connor AM; Pola S; Ward BM; Fillmore D; Buchanan KD; Kirwan JP
    Am J Physiol Endocrinol Metab; 2006 Jun; 290(6):E1155-61. PubMed ID: 16403776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meal frequency; does it determine postprandial lipaemia?
    Murphy MC; Chapman C; Lovegrove JA; Isherwood SG; Morgan LM; Wright JW; Williams CM
    Eur J Clin Nutr; 1996 Aug; 50(8):491-7. PubMed ID: 8863008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interrelationships among insulin, glucagon, and gastric inhibitory polypeptide in insulinoma.
    Nelson RL; Service FJ; Go VL
    Mayo Clin Proc; 1980 Mar; 55(3):138-45. PubMed ID: 6243728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diurnal profiles of gastrointestinal regulatory peptides.
    Jorde R; Burhol PG
    Scand J Gastroenterol; 1985 Jan; 20(1):1-4. PubMed ID: 2859649
    [No Abstract]   [Full Text] [Related]  

  • 39. Plasma lipid and lipoprotein levels in a Danish population.
    Dyerberg J; Hjorne N
    Acta Med Scand; 1972 May; 191(5):413-21. PubMed ID: 4337998
    [No Abstract]   [Full Text] [Related]  

  • 40. Radioimmunoassay of gastric inhibitory polypeptide.
    Morgan LM; Morris BA; Marks V
    Ann Clin Biochem; 1978 May; 15(3):172-7. PubMed ID: 677795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.